CD34, with its unique glycosylated structure as the ligand of L-selectin on lymphocytes, promotes the migration, adhesion, and aggregation of lymphocytes to the intestinal inflammatory sites during IBD (Maltby et al., 2010), participating in the initial stage of the inflammatory response, as shown in Figure 1. Here, SELL is linked to inflammatory bowel disease.